- Presentations
- 2
- Markets
- 1
Elrexfio is a brand of Elranatamab marketed by Pfizer Laboratories, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Elranatamab
- Brand owner
- Pfizer Laboratories
- Registered in
- United States
- Strengths and forms
- 44 mg/1.1 mL injection, 76 mg/1.9 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Elrexfio 44 mg/1.1 mL injectionSubcutaneous Cold chain | Pfizer Laboratories | US FDA | Available on request |
| Elrexfio 76 mg/1.9 mL injectionSubcutaneous Cold chain | Pfizer Laboratories | US FDA | Available on request |
Equivalent brands
Other brands of Elranatamab.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Elrexfio
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.